Lu X - Search Results

1

Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.

Wu Y, Xu X, Miao X, Zhu X, Yin H, He Y, Li C, Liu Y, Chen Y, Lu X, Wang Y, He S. Wu Y, et al. Among authors: lu x. Cell Prolif. 2015 Dec;48(6):682-90. doi: 10.1111/cpr.12220. Epub 2015 Oct 19. Cell Prolif. 2015. PMID: 26478515 Free PMC article.

2

ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.

Zhu X, Miao X, Wu Y, Li C, Guo Y, Liu Y, Chen Y, Lu X, Wang Y, He S. Zhu X, et al. Among authors: lu x. Exp Cell Res. 2015 Jul 15;335(2):216-23. doi: 10.1016/j.yexcr.2015.05.020. Epub 2015 May 27. Exp Cell Res. 2015. PMID: 26024773

3

Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.

Miao X, Xu X, Wu Y, Zhu X, Chen X, Li C, Lu X, Chen Y, Liu Y, Huang J, Wang Y, He S. Miao X, et al. Among authors: lu x. Tumour Biol. 2016 Jan;37(1):1369-78. doi: 10.1007/s13277-015-3939-4. Epub 2015 Aug 23. Tumour Biol. 2016. PMID: 26298725

4

Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.

He S, Miao X, Wu Y, Zhu X, Miao X, Yin H, He Y, Li C, Liu Y, Lu X, Chen Y, Wang Y, Xu X. He S, et al. Among authors: lu x. J Cancer Res Clin Oncol. 2016 Mar;142(3):561-72. doi: 10.1007/s00432-015-2057-4. Epub 2015 Oct 23. J Cancer Res Clin Oncol. 2016. PMID: 26498772

5

Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma.

Miao X, Wu Y, Wang Y, Zhu X, Yin H, He Y, Li C, Liu Y, Lu X, Chen Y, Shen R, Xu X, He S. Miao X, et al. Among authors: lu x. Exp Cell Res. 2016 Aug 15;346(2):157-66. doi: 10.1016/j.yexcr.2016.07.003. Epub 2016 Jul 8. Exp Cell Res. 2016. PMID: 27397581

6

High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.

Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, Chen X, He S. Zhu X, et al. Among authors: lu x. Tumour Biol. 2016 Nov;37(11):14615-14628. doi: 10.1007/s13277-016-5316-3. Epub 2016 Sep 12. Tumour Biol. 2016. PMID: 27619678

7

Low expression of PDHA1 predicts poor prognosis in gastric cancer.

Song L, Liu D, Zhang X, Zhu X, Lu X, Huang J, Yang L, Wu Y. Song L, et al. Among authors: lu x. Pathol Res Pract. 2019 Mar;215(3):478-482. doi: 10.1016/j.prp.2018.12.038. Epub 2018 Dec 31. Pathol Res Pract. 2019. PMID: 30611622

8

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.

Jin X, Wei Y, Liu Y, Lu X, Ding F, Wang J, Yang S. Jin X, et al. Among authors: lu x. Cancer Med. 2019 Mar;8(3):1246-1257. doi: 10.1002/cam4.1993. Epub 2019 Jan 29. Cancer Med. 2019. PMID: 30697969 Free PMC article.

9

Expression and significance of ETFDH in hepatocellular carcinoma.

Wu Y, Zhang X, Shen R, Huang J, Lu X, Zheng G, Chen X. Wu Y, et al. Among authors: lu x. Pathol Res Pract. 2019 Dec;215(12):152702. doi: 10.1016/j.prp.2019.152702. Epub 2019 Oct 23. Pathol Res Pract. 2019. PMID: 31704152

10

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma.

Song L, Chen Z, Zhang M, Zhang M, Lu X, Li C, Miao L. Song L, et al. Among authors: lu x. J Cancer. 2021 Sep 3;12(21):6422-6428. doi: 10.7150/jca.60118. eCollection 2021. J Cancer. 2021. PMID: 34659532 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,777 results

Search Page

Filters